Stockhub

Aptahem AB: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 August 2022

  • curprev 04:4604:46, 16 August 2022 >Paris 812 bytes +812 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Aptahem AB (publ), a biotechnology company, develops aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. Its principal pharmaceutical candidate is Apta-1, which is in pre-clinical stage to prevent mortality rate caused by organ and tissue damage in sepsis patients. The company has collaborations with various consultants and contract research laboratories, including The Nencki Institute of E..."
Retrieved from "https://stockhub.co/research/Aptahem_AB"